Grönemeyer Health

What Grönemeyer Health does

Grönemeyer Swiss Health AG (also doing business as Grönemeyer Health AG) is a privately held Swiss Aktiengesellschaft headquartered at Stockerstrasse 42 in Zürich that invests in innovative healthcare companies and provides advisory and distribution services for health products in Switzerland and Germany. The company manages a portfolio of 16 companies spanning Healthcare, MedTech, HealthTech, DigitalHealth and Health-Consumables, with named investments including my7sundays and Amedo, and a distribution partnership with Colombo in Switzerland. Its investment thesis follows the "World Medicine" philosophy articulated by founder Prof. Dr. Dietrich Grönemeyer, which combines high-tech medicine with naturopathy.

The company's core proprietary technology is microtherapy, a navigation-based minimally invasive treatment method pioneered by Prof. Dr. Grönemeyer that uses CT or MRI guidance to treat back pain, intervertebral disc conditions and tumors. The associated outpatient Grönemeyer Institute for Microtherapy, founded in 1997 in Bochum and later expanded to Berlin, Hamburg, Cologne and Stuttgart, employs approximately 30 interdisciplinary physicians and serves as the flagship clinical asset of the broader Grönemeyer Group. Beyond clinical operations, the founder's media presence — including a ZDF show since 2012 and a quarterly magazine published by the Funke Group since 2019 — extends the brand across German-speaking audiences.

Revenue is generated through two streams: investment returns from the healthcare portfolio (transaction/equity returns) and professional/managed services revenue from distribution consulting and partial direct distribution of innovative health products. No pricing models, contract values, headcount figures, or audited financials are publicly disclosed, leaving the firm's commercial scale unverified beyond qualitative claims of 1,000+ jobs created across medical centers, companies and investments.

Name

Grönemeyer Health

Legal name

Grönemeyer Swiss Health AG

Website

https://groenemeyer-health.ch

Company type

Private

Operating status

Operating

Short description

Grönemeyer Swiss Health AG is a Zürich-based private investment and distribution advisory firm that manages a 16-company healthcare portfolio and provides health-product distribution consulting in Switzerland and Germany, operating under Prof. Dr. Dietrich Grönemeyer's "World Medicine" philosophy.

Ownership category

akta.pro rank

Product category

Healthcare Investment and Advisory Services

NAICS

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345), Finance and Insurance (52)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Health Systems Strengthening & Primary Care Development (HLAJAKAJ)

akta.pro secondary industry

Health Access & Social Care Innovations (Community Health, Telehealth for Underserved) (BPAGALAG)

Keywords

• Healthcare investment services
• Medical distribution consulting
• Healthtech venture capital
• Digital health investments
• Microtherapy medical services

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Investment Returns: The company invests in innovative healthcare companies in Switzerland and Germany with growth potential, generating returns through equity appreciation and exits.
2. Distribution Consulting Services: The company provides consulting services for distribution of healthcare products and partially handles distribution of innovative products in the Health sector.
3. Portfolio Management: Management of a portfolio of 16 companies across Healthcare, MedTech, HealthTech, DigitalHealth & Health-Consumables sectors.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

Grönemeyer Swiss Health AG invests in innovative healthcare companies in Switzerland and Germany with growth potential, managing a portfolio of 16 companies spanning Healthcare, MedTech, HealthTech, DigitalHealth, and Health-Consumables. In parallel, the company provides consulting services for distribution of health products and partially handles distribution of innovative products in the health sector, ranging from High Tech and Digital Health to Naturopathy.

Product overview

Grönemeyer Swiss Health AG operates as an investment and advisory holding company rather than a technology product company. The core offering is investment management in healthcare companies, with a portfolio of 16 firms spanning Healthcare, MedTech, HealthTech, DigitalHealth, and Health-Consumables. The company also provides advisory services for distribution of health products in Switzerland and Germany, covering the spectrum from High Tech and Digital Health to Naturopathy. The flagship investment is the Grönemeyer Institute for Microtherapy, founded in 1997, which operates outpatient centers in Bochum, Berlin, Hamburg, Cologne, and Stuttgart with approximately 30 interdisciplinary treating physicians. The company was founded following the philosophy of Prof. Dr. Dietrich Grönemeyer, who pioneered microtherapy for minimally invasive treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Investment Advisory Services Investment and advisory services for innovative healthcare companies in Switzerland and Germany, covering the spectrum from High Tech to Digital Health and Naturopathy. Includes equity investment in growth companies and consulting services for the distribution of health products.
• Grönemeyer Institute for Microtherapy Outpatient medical center specializing in microtherapy — a navigation-based approach using CT or MRI for minimally invasive treatment of back pain, intervertebral disc conditions, and tumors. Founded in 1997 in Bochum with approximately 30 interdisciplinary treating physicians, later expanded to Berlin, Hamburg, Cologne, and Stuttgart.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered minor.

• my7sundaysminorStrategic or Co-development PartnerPortfolio company investment - Grönemeyer Swiss Health AG invests in my7sundays as an innovative healthcare company with growth potential in Switzerland and Germany.
• AmedominorStrategic or Co-development PartnerPortfolio company investment - Grönemeyer Swiss Health AG invests in Amedo as an innovative healthcare company with growth potential in Switzerland and Germany.
• ColombominorChannel Partner/ Reseller/ DistributorColombo is displayed as a partner in the distribution network for health products in Switzerland.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• HBM Partners: Swiss-based investment firm specializing exclusively in healthcare and life sciences across public and private markets. Comparable to Grönemeyer Health as a Zurich-anchored, healthcare-pure investment firm, though with disclosed institutional scale and a public-markets capability.
• BioMedPartners: Swiss-based venture capital firm investing in early- to late-stage healthcare and life sciences companies across Europe. Directly comparable to Grönemeyer Health as a Switzerland-domiciled, healthcare-focused VC with a similar thesis around backing innovative European health ventures.
• Wellington Partners: Munich-based venture capital firm with a dedicated life sciences practice investing in European therapeutics, MedTech, and digital health. Comparable to Grönemeyer Health in DACH geographic focus and healthcare sub-sector breadth across MedTech, HealthTech, and consumer health.
• Ysma AG: Zurich-based multi-family office founded by Dr. Sibylle Peter in 2017 with healthcare and sustainability mandates. Highly comparable to Grönemeyer Health given the personal overlap of board leadership and the shared Zurich family-office / healthcare-investment orientation.
• Endeavour Vision: Geneva-based growth-stage MedTech and digital health investor focused on European and US companies. Comparable to Grönemeyer Health as a Swiss-domiciled healthcare investor backing innovative growth companies, with overlapping MedTech and DigitalHealth exposure.
• Earlybird Venture Capital: Berlin-based pan-European VC with a dedicated HealthTech fund investing in digital health, MedTech, and biotech across Europe. Comparable to Grönemeyer Health as a DACH-anchored, multi-subsector healthcare investor backing growth-stage innovative health companies.
• MIG Capital: Munich-based venture capital firm with a strong track record of investing in innovative German and European deep-tech, life sciences, and healthcare companies. Comparable to Grönemeyer Health in DACH geographic focus and backing of innovative growth-stage ventures across multiple health subsectors.
• BGV (BioGeneration Ventures): European venture capital firm focused exclusively on early-stage biopharma and MedTech, with strong Dutch/German deal flow. Comparable to Grönemeyer Health in its healthcare-only mandate and European geographic focus on innovative growth-stage companies.

Broad incumbents

• Novartis Venture Fund: Switzerland-based corporate venture arm of Novartis investing in early-stage life sciences and digital health globally. Comparable to Grönemeyer Health as a Zurich-headquartered healthcare investor, but operating at vastly greater scale with a corporate-strategic mandate rather than a founder-family-office model.
• Asklepios Kliniken: One of Germany's largest private hospital operators running acute-care and outpatient facilities across multiple cities. Comparable to Grönemeyer Health's outpatient microtherapy footprint in Bochum, Berlin, Hamburg, Cologne, and Stuttgart as a German multi-site private medical operator.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grönemeyer Health